Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-07-08 Huizenga Theodore Alan SVP, Controller and PAO Exercise or conversion +2,000 $21.00 $42K 18,582
2020-07-08 Huizenga Theodore Alan SVP, Controller and PAO Sale −2,000 $91.00 $182K 16,582
2020-07-08 Huizenga Theodore Alan SVP, Controller and PAO Exercise or conversion · Stock Option (Right to Buy) −2,000 12,000
2020-07-06 Fust Matthew K Director Exercise or conversion +6,181 $21.00 $130K 19,731
2020-07-06 Fust Matthew K Director Sale −6,181 $90.00 $556K 13,550
2020-07-06 Fust Matthew K Director Exercise or conversion · Stock Option (Right to Buy) −6,181 0
2020-07-06 Harris Erik EVP & Chief Commercial Officer Shares withheld for taxes −260 $86.75 $23K 23,590
2020-07-01 Fust Matthew K Director Exercise or conversion +5,000 $21.00 $105K 18,550
2020-07-01 Fust Matthew K Director Sale −5,000 $85.00 $425K 13,550
2020-07-01 Fust Matthew K Director Exercise or conversion · Stock Option (Right to Buy) −5,000 6,181
2020-07-01 Huizenga Theodore Alan SVP, Controller and PAO Sale −1,111 $81.00 $90K 17,220
2020-07-01 Huizenga Theodore Alan SVP, Controller and PAO Exercise or conversion +1,500 $21.00 $32K 18,720
2020-07-01 Huizenga Theodore Alan SVP, Controller and PAO Sale −1,500 $81.00 $122K 17,220
2020-07-01 Huizenga Theodore Alan SVP, Controller and PAO Exercise or conversion · Stock Option (Right to Buy) −1,500 14,000
2020-06-26 WELCH DANIEL G Director Grant or award +2,550 12,300
2020-06-26 WELCH DANIEL G Director Grant or award · Stock Option (Right to Buy) +4,250 4,250
2020-06-26 SULIMAN SHEHNAAZ Director Grant or award +2,550 5,550
2020-06-26 SULIMAN SHEHNAAZ Director Grant or award · Stock Option (Right to Buy) +4,250 4,250
2020-06-26 SIEGALL CLAY B Director Grant or award +2,550 12,300
2020-06-26 SIEGALL CLAY B Director Grant or award · Stock Option (Right to Buy) +4,250 4,250

Page 26 of 32 · 632 trades